Abatacept in Patients With Birdshot HLA A29 Uveitis

NCT03871361 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Eye Diseases
Uveitis

Interventions

DRUG: Abatacept 125 MG/ML Prefilled Syringe

Sponsor

Universitaire Ziekenhuizen KU Leuven

Collaborators

[object Object]